Novel self‐expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis
Open Access
- 17 November 2021
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (4) , 1234-1242
Abstract
Objectives: To investigate the safety and efficacy of the ALLEGRA valve in routine use.Background: The ALLEGRA aortic valve is a self‐expanding transcatheter heart valve (THV) with bovine pericardial tissue and was CE approved in March 2017. Its unique design was developed to provide low prosthesis gradients.Methods: We analyzed patients receiving an ALLEGRA THV between May 2017 and March 2021 at our center for treatment of aortic valve stenosis or degenerated valve prosthesis. Hemodynamic results and clinical outcome according to the Valve Academic Research Consortium‐2 consensus criteria were evaluated at discharge and three months post transcatheter aortic valve replacement (TAVR) procedure. 93 patients with a mean age of 82.5 ± 4.8 years and a median EuroScore II of 4.7 ± 3.4 were treated, 15 of them were valve‐in‐valve procedures.Results: Implantation was successful in 97.8% (91/93) and VARC‐2 defined device success was achieved in 94.6% (88/93). In‐hospital all‐cause mortality was 2.2% (2/93). Life‐threatening bleeding, major vascular complications and strokes were 3.2% (3/93), 2.2% (2/93) and 3.2% (3/93), respectively. Paravalvular leakage was none to trace in 60.4%, mild in 38.5% and moderate in 1.1%. Permanent pacemaker implantation in pacemaker naive patients was necessary in 9.5% (8/84). Mean gradient at discharge was 8.2 ± 4.3 mmHg for all patients; 7.1 ± 2.6 mmHg in patients treated for stenosis of the native aortic valve and 13.8 ± 6.3 mmHg in patients treated valve‐in‐valve.Conclusions: The ALLEGRA THV provides excellent hemodynamic results and a good safety profile with a low complication rate.Keywords
This publication has 24 references indexed in Scilit:
- First‐in‐human implantation of a novel self‐expanding supra‐annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesisCatheterization and Cardiovascular Interventions, 2018
- Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysisInternational Journal of Cardiology, 2017
- Normal values for Doppler echocardiographic assessment of prosthetic valve function after transcatheter aortic valve replacement: a systematic review and meta-analysisEuropean Heart Journal - Cardiovascular Imaging, 2017
- Impact of closure devices on vascular complication and mortality rates in TAVI proceduresInternational Journal of Cardiology, 2017
- Quality of Life After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2016
- Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valveEuroIntervention, 2016
- Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic ValveJACC: Cardiovascular Imaging, 2015
- Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve ReplacementJAMA, 2014
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)European Journal of Cardio-Thoracic Surgery, 2012
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010